Corbin Capital Partners, L.P. Alpha Tau Medical Ltd. Transaction History
Corbin Capital Partners, L.P.
- $35.7 Million
- Q2 2024
A detailed history of Corbin Capital Partners, L.P. transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Corbin Capital Partners, L.P. holds 97,197 shares of DRTS stock, worth $221,609. This represents 0.69% of its overall portfolio holdings.
Number of Shares
97,197
Previous 260,109
62.63%
Holding current value
$221,609
Previous $767,000
68.06%
% of portfolio
0.69%
Previous 1.86%
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.42MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY280KShares$639,4460.07% of portfolio
-
Hoyle Cohen, LLC269KShares$613,5200.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$526,0050.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$151,2230.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$122,2210.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $157M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...